175 related articles for article (PubMed ID: 31604525)
1. Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd.
Shababi M; Smith CE; Kacher M; Alrawi Z; Villalón E; Davis D; Bryda EC; Lorson CL
Biochem Biophys Res Commun; 2019 Dec; 520(2):341-346. PubMed ID: 31604525
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Grohmann K; Rossoll W; Kobsar I; Holtmann B; Jablonka S; Wessig C; Stoltenburg-Didinger G; Fischer U; Hübner C; Martini R; Sendtner M
Hum Mol Genet; 2004 Sep; 13(18):2031-42. PubMed ID: 15269181
[TBL] [Abstract][Full Text] [Related]
3. The ultrastructure of peripheral nerve, motor end-plate and skeletal muscle in patients suffering from spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Diers A; Kaczinski M; Grohmann K; Hübner C; Stoltenburg-Didinger G
Acta Neuropathol; 2005 Sep; 110(3):289-97. PubMed ID: 16025284
[TBL] [Abstract][Full Text] [Related]
4. Selective vulnerability in neuronal populations in nmd/SMARD1 mice.
Villalón E; Shababi M; Kline R; Lorson ZC; Florea KM; Lorson CL
Hum Mol Genet; 2018 Feb; 27(4):679-690. PubMed ID: 29272405
[TBL] [Abstract][Full Text] [Related]
5. Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy.
Maddatu TP; Garvey SM; Schroeder DG; Hampton TG; Cox GA
Hum Mol Genet; 2004 Jun; 13(11):1105-15. PubMed ID: 15069027
[TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.
Vanoli F; Rinchetti P; Porro F; Parente V; Corti S
J Cell Mol Med; 2015 Sep; 19(9):2058-66. PubMed ID: 26095024
[TBL] [Abstract][Full Text] [Related]
7. Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent.
Shababi M; Feng Z; Villalon E; Sibigtroth CM; Osman EY; Miller MR; Williams-Simon PA; Lombardi A; Sass TH; Atkinson AK; Garcia ML; Ko CP; Lorson CL
Mol Ther; 2016 May; 24(5):855-66. PubMed ID: 26860981
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol-coupled IGF1 delays motor function defects in a mouse model of spinal muscular atrophy with respiratory distress type 1.
Krieger F; Elflein N; Saenger S; Wirthgen E; Rak K; Frantz S; Hoeflich A; Toyka KV; Metzger F; Jablonka S
Brain; 2014 May; 137(Pt 5):1374-93. PubMed ID: 24681663
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery.
de Planell-Saguer M; Schroeder DG; Rodicio MC; Cox GA; Mourelatos Z
Hum Mol Genet; 2009 Jun; 18(12):2115-26. PubMed ID: 19299493
[TBL] [Abstract][Full Text] [Related]
10. Severe phenotypes of SMARD1 associated with novel mutations of the IGHMBP2 gene and nuclear degeneration of muscle and Schwann cells.
Jędrzejowska M; Madej-Pilarczyk A; Fidziańska A; Mierzewska H; Pronicka E; Obersztyn E; Gos M; Pronicki M; Kmieć T; Migdał M; Mierzewska-Schmidt M; Walczak-Wojtkowska I; Konopka E; Hausmanowa-Petrusewicz I
Eur J Paediatr Neurol; 2014 Mar; 18(2):183-92. PubMed ID: 24388491
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.
Grohmann K; Schuelke M; Diers A; Hoffmann K; Lucke B; Adams C; Bertini E; Leonhardt-Horti H; Muntoni F; Ouvrier R; Pfeufer A; Rossi R; Van Maldergem L; Wilmshurst JM; Wienker TF; Sendtner M; Rudnik-Schöneborn S; Zerres K; Hübner C
Nat Genet; 2001 Sep; 29(1):75-7. PubMed ID: 11528396
[TBL] [Abstract][Full Text] [Related]
12. Current understanding of and emerging treatment options for spinal muscular atrophy with respiratory distress type 1 (SMARD1).
Perego MGL; Galli N; Nizzardo M; Govoni A; Taiana M; Bresolin N; Comi GP; Corti S
Cell Mol Life Sci; 2020 Sep; 77(17):3351-3367. PubMed ID: 32123965
[TBL] [Abstract][Full Text] [Related]
13. Impaired Local Translation of β-actin mRNA in Ighmbp2-Deficient Motoneurons: Implications for Spinal Muscular Atrophy with respiratory Distress (SMARD1).
Surrey V; Zöller C; Lork AA; Moradi M; Balk S; Dombert B; Saal-Bauernschubert L; Briese M; Appenzeller S; Fischer U; Jablonka S
Neuroscience; 2018 Aug; 386():24-40. PubMed ID: 29928949
[TBL] [Abstract][Full Text] [Related]
14. Defining the optimal dose and therapeutic window in SMA with respiratory distress type I model mice, FVB/NJ-
Shababi M; Smith CE; Ricardez Hernandez SM; Marquez J; Al Rawi Z; Villalón E; Farris KD; Garro-Kacher MO; Lorson CL
Mol Ther Methods Clin Dev; 2021 Dec; 23():23-32. PubMed ID: 34553000
[TBL] [Abstract][Full Text] [Related]
15. Growing up with spinal muscular atrophy with respiratory distress (SMARD1).
Hamilton MJ; Longman C; O'Hara A; Kirkpatrick M; McWilliam R
Neuromuscul Disord; 2015 Feb; 25(2):169-71. PubMed ID: 25454169
[TBL] [Abstract][Full Text] [Related]
16. Fast motor axon loss in SMARD1 does not correspond to morphological and functional alterations of the NMJ.
Krieger F; Elflein N; Ruiz R; Guerra J; Serrano AL; Asan E; Tabares L; Jablonka S
Neurobiol Dis; 2013 Jun; 54():169-82. PubMed ID: 23295857
[TBL] [Abstract][Full Text] [Related]
17. Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1.
Villalón E; Lee NN; Marquez J; Lorson CL
Biochem Biophys Res Commun; 2019 Aug; 516(1):313-319. PubMed ID: 31256932
[TBL] [Abstract][Full Text] [Related]
18. Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival.
Maddatu TP; Garvey SM; Schroeder DG; Zhang W; Kim SY; Nicholson AI; Davis CJ; Cox GA
Hum Mol Genet; 2005 Nov; 14(21):3179-89. PubMed ID: 16174646
[TBL] [Abstract][Full Text] [Related]
19. The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review.
Porro F; Rinchetti P; Magri F; Riboldi G; Nizzardo M; Simone C; Zanetta C; Faravelli I; Corti S
J Neurol Sci; 2014 Nov; 346(1-2):35-42. PubMed ID: 25248952
[TBL] [Abstract][Full Text] [Related]
20. The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects.
Smith CE; Lorson MA; Ricardez Hernandez SM; Al Rawi Z; Mao J; Marquez J; Villalón E; Keilholz AN; Smith CL; Garro-Kacher MO; Morcos T; Davis DJ; Bryda EC; Nichols NL; Lorson CL
Hum Mol Genet; 2022 Apr; 31(8):1293-1307. PubMed ID: 34726235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
